Levocetirizine for chronic idiopathic urticaria: a review

Only recently available on the US market, levocetirizine has emerged as an effective new option in the treatment of chronic idiopathic urticaria (CIU). Levocetirizine is the active isomer of cetirizine and demonstrates twice the affinity for the H1 receptor compared with the parent compound. In the...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of drugs in dermatology Vol. 8; no. 3; p. 243
Main Authors:	Ducharme, Erin E, Weinberg, Jeffrey M
Format:	Journal Article
Language:	English
Published:	United States 01-03-2009
Subjects:	Cetirizine - adverse effects Cetirizine - economics Cetirizine - therapeutic use Chronic Disease Cost-Benefit Analysis Histamine H1 Antagonists, Non-Sedating - adverse effects Histamine H1 Antagonists, Non-Sedating - economics Histamine H1 Antagonists, Non-Sedating - therapeutic use Humans Urticaria - drug therapy
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Only recently available on the US market, levocetirizine has emerged as an effective new option in the treatment of chronic idiopathic urticaria (CIU). Levocetirizine is the active isomer of cetirizine and demonstrates twice the affinity for the H1 receptor compared with the parent compound. In the treatment of CIU, levocetirizine has consistently demonstrated high response rates, fast onset, and a favorable side effect profile.
ISSN:	1545-9616